178 related articles for article (PubMed ID: 18323857)
1. NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL.
Russell RC; Ohh M
EMBO Rep; 2008 May; 9(5):486-91. PubMed ID: 18323857
[TBL] [Abstract][Full Text] [Related]
2. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
Bonicalzi ME; Groulx I; de Paulsen N ; Lee S
J Biol Chem; 2001 Jan; 276(2):1407-16. PubMed ID: 11024059
[TBL] [Abstract][Full Text] [Related]
3. Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex.
Sufan RI; Ohh M
Neoplasia; 2006 Nov; 8(11):956-63. PubMed ID: 17132228
[TBL] [Abstract][Full Text] [Related]
4. DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.
Heir P; Sufan RI; Greer SN; Poon BP; Lee JE; Ohh M
Mol Cell Biol; 2013 Apr; 33(8):1621-31. PubMed ID: 23401859
[TBL] [Abstract][Full Text] [Related]
5. pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.
Stickle NH; Chung J; Klco JM; Hill RP; Kaelin WG; Ohh M
Mol Cell Biol; 2004 Apr; 24(8):3251-61. PubMed ID: 15060148
[TBL] [Abstract][Full Text] [Related]
6. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.
Hansen WJ; Ohh M; Moslehi J; Kondo K; Kaelin WG; Welch WJ
Mol Cell Biol; 2002 Mar; 22(6):1947-60. PubMed ID: 11865071
[TBL] [Abstract][Full Text] [Related]
7. Identification of Elongin C and Skp1 sequences that determine Cullin selection.
Yan Q; Kamura T; Cai Y; Jin J; Ivan M; Mushegian A; Conaway RC; Conaway JW
J Biol Chem; 2004 Oct; 279(41):43019-26. PubMed ID: 15280393
[TBL] [Abstract][Full Text] [Related]
8. The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to cullin-2.
Wada H; Yeh ET; Kamitani T
J Biol Chem; 1999 Dec; 274(50):36025-9. PubMed ID: 10585493
[TBL] [Abstract][Full Text] [Related]
9. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
[TBL] [Abstract][Full Text] [Related]
10. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
Yun J; Kim YI; Tomida A; Choi CH
Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function.
Liakopoulos D; Büsgen T; Brychzy A; Jentsch S; Pause A
Proc Natl Acad Sci U S A; 1999 May; 96(10):5510-5. PubMed ID: 10318914
[TBL] [Abstract][Full Text] [Related]
12. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
13. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
Clifford SC; Cockman ME; Smallwood AC; Mole DR; Woodward ER; Maxwell PH; Ratcliffe PJ; Maher ER
Hum Mol Genet; 2001 May; 10(10):1029-38. PubMed ID: 11331613
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
Cardote TAF; Gadd MS; Ciulli A
Structure; 2017 Jun; 25(6):901-911.e3. PubMed ID: 28591624
[TBL] [Abstract][Full Text] [Related]
16. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
[TBL] [Abstract][Full Text] [Related]
17. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
[TBL] [Abstract][Full Text] [Related]
18. The COP9/signalosome increases the efficiency of von Hippel-Lindau protein ubiquitin ligase-mediated hypoxia-inducible factor-alpha ubiquitination.
Miyauchi Y; Kato M; Tokunaga F; Iwai K
J Biol Chem; 2008 Jun; 283(24):16622-31. PubMed ID: 18424433
[TBL] [Abstract][Full Text] [Related]
19. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
20. Proteomic dissection of the von Hippel-Lindau (VHL) interactome.
Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2011 Nov; 10(11):5175-82. PubMed ID: 21942715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
